6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ylacetic acid | 95838-39-4

• 分子结构分类: 有机化合物 - 苯类化合物
• 英文名称: 6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ylacetic acid
• 英文别名: (6,7,8,9-Tetrahydro-5H-benzocyclohepten-5-yl)essigsaeure；2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl)acetic acid
• CAS: 95838-39-4
• 化学式: C₁₃H₁₆O₂
• 分子量: 204.269
• InChiKey: FYGBFBQPBKHOMB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ylacetic acid 在 氯化亚砜 、 N,N-二甲基甲酰胺 作用下， 以 二氯甲烷 为溶剂， 生成 (6,7,8,9-Tetrahydro-5H-benzocyclohepten-5-yl)essigsaeurechlorid
  参考文献：
  名称：

  Regioselective Dearomative Amidoximation of Nonactivated Arenes Enabled by Photohomolytic Cleavage of N‐nitrosamides

  摘要：

  摘要脱芳基螺环化反应是将烷烃转化为三维结构的一种很有前景的方法；然而，控制非活化烷烃脱芳基反应的区域选择性，以获得螺环化的 1,2-二官能度，而不是其动力学上偏好的 1,4-二官能度，却极具挑战性。在这里，我们揭示了一种新策略，即通过可见光直接诱导亚硝酰胺的 N-NO 键的均裂，实现（杂）烷的 1,2- 或 1,4- 氨基肟化，从而产生各种高区域选择性的氨基肟化螺环，而这些螺环以前是无法获得的，或者需要精心的合成工作。通过对照实验和密度泛函理论计算，研究了观察到的区域选择性的机理和起源。

  DOI：

  10.1002/anie.202317968
• 作为产物：
  描述：

  cyano-(6,7,8,9-tetrahydro-benzocyclohepten-5-yliden)-acetic acid ethyl ester 在 盐酸 、 乙醇 、 铂 作用下， 生成 6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ylacetic acid
  参考文献：
  名称：

  Dev, Journal of the Indian Chemical Society, 1955, vol. 32, p. 513,523

  摘要：

  DOI：

文献信息

• Direct β-Selective Hydrocarboxylation of Styrenes with CO₂ Enabled by Continuous Flow Photoredox Catalysis
  作者：Hyowon Seo、Aofei Liu、Timothy F. Jamison

  DOI：10.1021/jacs.7b05942

  日期：2017.10.11

  The direct β-selective hydrocarboxylation of styrenes under atmospheric pressure of CO2 has been developed using photoredox catalysis in continuous flow. The scope of this methodology was demonstrated with a range of functionalized terminal styrenes, as well as α-substituted and β-substituted styrenes.

  已经在连续流动中使用光氧化还原催化开发了在 CO2 大气压下苯乙烯的直接 β-选择性加氢羧化反应。该方法的范围通过一系列官能化的末端苯乙烯以及 α-取代和 β-取代的苯乙烯进行了证明。
• TRICYCLIC AMINE COMPOUND
  申请人：Research Foundation Itsuu Laboratory

  公开号：EP2189440A1

  公开（公告）日：2010-05-26

  A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C16 alkyl group, A and B represent -(CH2)2-, -(CH2)3- or -(CH2)4-, X represents -N(R2)- (R2 represents hydrogen atom or a C1-6 alkyl group), -CO-, -C(=N-R3)- (R3 represents hydrogen atom or a C1-6 alkyl group), or - C(=C(R4)(R5))- (R4 and R5 independently represent hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has an action of controlling physiological activities of retinoids and useful as an active ingredient of a medicament.

  通用公式（I）代表的化合物：[其中R1代表氢原子或C16烷基，A和B代表-(CH2)2-，-(CH2)3-或-(CH2)4-，X代表-N(R2)-（R2代表氢原子或C1-6烷基），-CO-，-C(=N-R3)-（R3代表氢原子或C1-6烷基），或-C(=C(R4)(R5))-（R4和R5独立代表氢原子或C1-6烷基），Ar代表芳基二基团或杂芳基二基团]，具有控制视黄醇生理活性的作用，并可用作药物的活性成分。
• Synthetic and structural studies of [6]-, [7]- and [10]metacyclophanes
  作者：S. Hirano、H. Hara、T. Hiyama、S. Fujita、H. Nozaki

  DOI：10.1016/0040-4020(75)80219-5

  日期：1975.1

  between the aromatic bromine and the aliphatic hydrogen intraannularly opposed to be removed as HBr. Spectrometric study gives quantitative data of the dependence of the molecular geometry upon the chain length and the aromatic substituents. The energy barriers ΔGc≠ of the conformational flipping are 17·4 kcal/mol (Tc 76·5°) for [6]metacyclophane (7a), 11·5 kcal/mol (Tc −28°) for [7]metacyclophane (7b),

  由2,3-聚亚甲基-2-环戊烯酮的新制备序列5至2,6- polymethylenebromobenzenes 3（N = 6，7，10）和2,6- polymethylenephenyllithiums 6已被发现。6与各种亲电试剂的反应产生了许多新化合物，以揭示被聚亚甲基链包围的芳基C-Li部分的独特反应性。3a和3b的光解可提供跨环产物8、10和11，所有这些都是由于芳族溴与环状内相对的脂族氢之间的接近而产生的，因此被作为HBr除去。光谱研究给出了分子几何形状对链长和芳族取代基的依赖性的定量数据。能垒ΔG Ç ≠构象翻转的是17·4千卡/摩尔（T Ç 76·5°）为[6] metacyclophane（7A），11·5千卡/摩尔（T C ^ -28°）为[7 ]亚甲基环（7b），[10]亚甲基（7c）为·8 kcal / mol 。在[6] metacyclophane衍生物的脂族链
• Characterization of Potent and Selective Antagonists at Postsynaptic 5-HT1A Receptors in a Series of N4-Substituted Arylpiperazines
  作者：Jean-Louis Peglion、Herve Canton、Karin Bervoets、Valerie Audinot、Mauricette Brocco、Alain Gobert、Sylvie Le Marouille-Girardon、Mark J. Millan

  DOI：10.1021/jm00020a020

  日期：1995.9

  Benzocycloalkyl and benzocycloalkenyl moities linked, directly or via an alkyl chain, to oxygen-bearing heteroarylpiperazines were synthesized, in an attempt to obtain potent and selective antagonists at postsynaptic 5-HT1A receptors. From the numerous arylpiperazines described in the literature, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)pipe (3a) was chosen as a model of an arylpiperazine in view of its selectivity for 5-HT1A receptors versus alpha(1)-, alpha(2)-, and beta-adrenergic receptors, as well as dopamine D-1 and D-2 receptors. Two other closely-related arylpiperazines, 1-(1,5-benzodioxepin-6-yl)piperazine (3b) and 1-(benzofuran-7-yl)piperazine (3c), were also examined in this study. Al compounds showed high affinity at 5-HT1A sites (8.10 less than or equal to pK(i)s less than or equal to 9.35), and the majority behaved as antagonists in vivo in blocking the hypothermia induced by the 5-HT1A agonist 8-OH-DPAT in the absence of a marked effect alone at equivalent doses. An in vivo evaluation of dopamine D-2 receptor antagonist properties revealed that the majority of compounds was devoid of activity at this site, in marked contrast to BMY 7378 which displayed virtually no selectivity for 5-HT1A versus dopamine D-2 receptors. Moreover, six compounds of the present series, 8, 10, 11, 14, 25, and, 37, showed > 10-fold selectivity in vitro for 5-HT1A versus alpha(1)-adrenergic receptors. Compound 14 displayed an optimal compromise between potency (pK(i) = 8.75), marked antagonist activity, and selectivity toward alpha(1)-adrenergic (81-fold) and dopamine D-2 (195-fold) receptors. These characteristics clearly distinguish 14 from previously-reported ligands such as the postsynaptic 5-HT1A antagonist BMY 7378 and the weak partial agonist NAN 190 which, in contrast to the compounds of this series, belong to the well-exemplified class of imido derivatives of (o-methoxyphenyl)piperazines. The availability of 14 (S 15535) should facilitate the further elucidation of the functional role and potential therapeutic significance of 5-HT1A receptors.
• TRICYCLIC AMIDE COMPOUND
  申请人：Research Foundation Itsuu Laboratory

  公开号：EP2189443B1

  公开（公告）日：2013-10-23